A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people's risk of developing basal cell cancers or squamous cell cancers ...

However, metformin did not protect Black patients against squamous cell carcinoma specifically. “This study strengthens the evidence supporting metformin's potential as a protective agent ...

Patients with type 2 diabetes (T2D) on metformin face a lower risk for all-cause dementia than those not on metformin, with the protective effect being particularly evident in patients with ...